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Abstract
We aimed to assess whether pri-miRNA SNPs (miSNPs) could influence monocyte gene expression, either through marginal
association or by interacting with polymorphisms located in 3’UTR regions (3utrSNPs). We then conducted a genome-wide
search for marginal miSNPs effects and pairwise miSNPs63utrSNPs interactions in a sample of 1,467 individuals for which
genome-wide monocyte expression and genotype data were available. Statistical associations that survived multiple testing
correction were tested for replication in an independent sample of 758 individuals with both monocyte gene expression
and genotype data. In both studies, the hsa-mir-1279 rs1463335 was found to modulate in cis the expression of LYZ and in
trans the expression of CNTN6, CTRC, COPZ2, KRT9, LRRFIP1, NOD1, PCDHA6, ST5 and TRAF3IP2 genes, supporting the role of
hsa-mir-1279 as a regulator of several genes in monocytes. In addition, we identified two robust miSNPs 6 3utrSNPs
interactions, one involving HLA-DPB1 rs1042448 and hsa-mir-219-1 rs107822, the second the H1F0 rs1894644 and hsa-mir-
659 rs5750504, modulating the expression of the associated genes. As some of the aforementioned genes have previously
been reported to reside at disease-associated loci, our findings provide novel arguments supporting the hypothesis that the
genetic variability of miRNAs could also contribute to the susceptibility to human diseases.
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Introduction
MicroRNAs (miRNAs) represent a class of small (,19–29
nucleotides) non coding RNAs that participate in gene post-
transcriptional regulation. By binding to complementary target
sites that are mainly located in gene 3’UTR regions, miRNAs
inhibit mRNA translation either via mRNA degradation or via
repression of mRNA translation [1]. A complete or nearly
complete match of the miRNA with its target sequence generally
results in a decrease of gene expression while a mismatch lead to a
repression of mRNA translation. In general, miRNAs participate
in regulating the expression of genes located remote from their
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genomic sequence; however when miRNAs are located within
gene introns they are highly likely to modulate the expression of
the host gene [2,3].
According to the latest miRNA reference database (miRBase
release 18, www.mirbase.org) [4], it is estimated that more than
1,500 miRNAs could exist in humans. A given miRNA may have
several mRNA targets and participates in the regulation of a
network of genes with genomic sequence similarities [5].
Reciprocally, a given mRNA may harbour in its 3’UTR region
several different miRNA target sites and then be under the control
of a set of miRNAs. It is estimated that, overall, about 50% of the
genome would be subject to regulation by miRNAs [6,7], making
them one of the most important component of a cell. It is then not
surprising to find miRNAs associated with a large number of
human diseases (,300 diseases according to the human miRNA
disease database [8]) including cardiovascular and metabolic
disorders [9–12].
As with any genomic sequence, miRNAs are prone to
nucleotide variations that may have non negligible effects. The
presence of a single nucleotide polymorphism (SNP) in the long
miRNA primary (pri-miRNA) may affect its maturation process,
its expression or the binding of the mature form to its target, which
would then influence the expression of the target genes [13,14].
This is the case, for example, for rs11614913 located in the pri-
miRNA-196. It is hypothesized that this SNP affects miR-196a-2
expression, alters the miRNA–target binding site and influences
cancer risks [15,16]. The existence of a SNP in the miRNA
genomic sequence may create mature miRNA variants, named
isomiRs, whose predicted targets could differ from the original
miRNA’s targets [17]. In addition, the expression of miRNAs is
known to be regulated by transcriptional factors, and by
polymorphisms within the transcription factor binding sites, which
may then modulate miRNA expression [18]. Finally, the presence
of a SNP in the miRNA target sequences could also influence the
expression of the targeted mRNAs [19,20]. As an example, the
rs58186-C allele located in the 3’UTR region of the AGTR1 gene
has been shown to decrease the efficiency of the binding of miR-
155 to this gene. leading to an increase in AGTR1 expression [20].
In this study, we conducted a genome-wide investigation of the
effect of pri-miRNA SNPs (miSNPs) on monocyte gene expression
in a large epidemiological study of healthy subjects for whom
genome-wide monocyte gene expressions and genotype data have
been collected, as part of the Gutenberg Health Study [21–24].
We also conducted a genome-wide search for pair-wise interac-
tions between miSNPs and SNPs located in 3’UTR regions
(3utrSNPs). We reasoned that such investigation could help to
identify novel miRNA-sensitive regulation of gene expression in a
key cell type participating in several disease processes including
inflammation, atherosclerosis and immunity [25]. miSNPs effects
identified were further validated for replication in a second large
monocyte expression dataset, the Cardiogenics Transcriptomic
Study (CTS) [26].
Results
The Gutenberg Health Study (GHS) comprised 1,467 individ-
uals (750 men and 717 women) [23]. All these individuals were
typed for common SNPs using the Affymetrix Genome-Wide
Human SNP Array 6.0 and their monocyte expression profiles
were obtained from the Illumina HT-12 v3 Beadchip. Detailed
description of these genome-wide expression and genotype data
has already been provided elsewhere [21–24].
Probes and SNPs selection
The GRCH37 release of the Human reference genome and the
17th release of the miRNA database [4] were used to identify SNPs
located within pri-miRNA sequences and 3’UTR regions. The
number of miSNPs genotyped in GHS, or that could be
substituted according to the SNAP software [27] by a ‘‘proxy’’
genotyped SNP in strong correlation (when expressed in terms of a
pairwise linkage disequilibrium (LD) r2greater than 0.90) was 294,
representing 258 distinct miRNAs.
The pre-processing of the expression data (see Methods)
identified 22,004 probes covering 15,786 genes of ‘‘perfect’’
quality score according to ReMOAT [28] and not harboring a
SNP in their genomic sequence. These probes were then tested for
association with all genotyped miSNPs.
The search for interactions between miSNPs and 3utrSNP was
restricted to probes targeting genes known to contain SNPs in their
3’UTR region that were either directly genotyped in GHS, or
tagged by genotyped SNPs (r2.0.90). This led to the selection of a
subsample of 8,768 probes characterizing 6,147 genes. In these
genes, the total number of 3utrSNPs (or ‘‘proxy’’) that were further
studied was 10,783. The distribution of the number of 3utrSNPs
per gene is given in Table 1.
Association of miSNPs with gene expression
GHS discovery phase. This analysis can be viewed as an
ancillary study of the whole genome-wide association study
between all genotyped SNPs and all expressions already conducted
in GHS and whose results can be found in a publicly available
resource [23]. At the Bonferroni correction level of 7.7361029 (ie.
0.05/(294622,004)), fifty-seven associations between miSNPs and
gene expression were significant (Table S1). However, forty-eight
of these associations implicated miSNPs proxies mapping the
genomic region of the genes they were associated with. We
interrogated the GHS express database to identify the SNPs
showing the strongest association with the associated expression
among those with p,5.5061025 and located within 1Mb of the
probe genomic sequence, thereafter referred to as the best cis
eSNPs [23]. In six cases, the miSNP proxies were the best cis
eSNPs. After adjusting for the effect of the best cis eSNPs, most
miSNPs association vanished and only seven (bold lines in Table
S1) remained significant at p = 7.7361029. Most of these 48 cis
miSNPs associations are then likely due to LD between miSNPs
and ‘‘true’’ cis eSNPs. Nevertheless, this must be investigated in
greater depth as in several examples the corresponding miRNA
was located within an intron of the associated gene, and could
therefore participate in the regulation of the host gene.
Of more interest are the nine genome-wide significant
associations that involved a miSNP located on a chromosome
distinct from the one mapped by the associated gene, so called trans
associations referring to associations involving SNPs that are
located more than 1Mb away, or a distinct chromosome, from the
associated probe. As shown in Table 2, the hsa-mir-1279 SNP
rs1463335, tagged by the SNP rs317657 (r2 = 1.0), was associated
in cis with expression of LYZ (R2 = 20.1%; p= 1.36610276) and
YEATS4 (R2= 13.1%; p= 1.32610246), and in trans with expres-
sion of CNTN6 (R2 = 3.3%; p= 1.16610212), CTRC (R2= 3.5%;
p= 1.39610213), COPZ2 (R2 = 3.0%; p= 2.33610211), KRT9
(R2 = 4.5%; p= 1.15610215), LRRFIP1 (R2 = 10.0%;
p= 1.50610235), NOD1 (R2 = 2.1%; p= 7.2561029), PCDHA6
(R2 = 9.2%; p= 9.44610233), ST5 (R2= 5.1%; p= 2.05610218)
and TRAF3IP2 (R2= 4.9%; p= 2.74610217). It is of note that
whereas the rs317657-C allele, with minor allele frequency 0.46,
was associated with increased expression of LYZ, YEATS4 and
NOD1, it was associated with decreased levels of CNTN6, CTRC,
miRNA SNPs and Monocyte Gene Expression
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COPZ2, KRT9, LRRFIP1, PCDHA6, ST5 and TRAF3IP2 expres-
sion. After adjusting for the best LYZ cis eSNP, the association of
rs317657 with LYZ expression still retained genome-wide signif-
icance (p= 6.17610211) while the association with YEATS4
disappeared (p = 0.734) (Table S1). According to the TargetScan
bioinformatics tool [5], the position 648 to 654 of the 3’UTR LYZ
region is predicted to be complementary at 8 bases with the hsa-
mir-1279 sequence. This type of matching configuration, called
8mer, is usually considered to be a good prior for predicting
potential targets of miRNA. After adjusting for LYZ expression,
the trans association observed with rs317657 were reduced, but
remained highly significant, p = 3.88610211, p = 1.1561027,
p = 2.5261026, p = 1.65610210, p = 7.16610229,
p = 2.4461025, p = 8.23610228, p = 1.81610213,
p = 5.66610210 for CNTN6, CTRC, COPZ2, KRT9, LRRFIP1,
NOD1, PCDHA6, ST5 and TRAF3IP2, respectively. Corresponding
p-values for the trans associations adjusted for YEATS4 expression
were p= 1.8661029, p = 1.72610211, p = 6.4561029,
p = 9.48610212, p = 6.10610228, p = 3.76610213,
p = 1.59610228, p = 2.33610213, p = 5.1061028, respectively.
When the trans associations were adjusted for both LYZ and
YEATS4 expressions, they were hardly modified, with p-values
ranging between p=2.9861026 (COPZ2) to p = 6.55610227
(PCDHA6). As indicated in Table 3, these nine genes were not
strongly correlated with each other, nor with expression of LYZ,
the gene in which the rs31757 SNP was located.
Replication in CTS. We focused on the genome-wide
significant trans associations observed with the hsa-mir-1279
miSNP proxy. These associations were tested for replication in
CTS where monocyte expression was measured in a sample of 395
healthy individuals and 363 patients with coronary artery disease
[26]. In CTS, the hsa-mir-1279 rs1463335 proxy was the
rs998022 (r2 = 0.90). Its pairwise r2 with the GHS rs317657 proxy
was 0.84. The probe tagging the LYZ gene expression was not
available in CTS, but all other associations were replicable. As
indicated in Table 2, they all replicated with consistent pattern of
association as in GHS. The rs998022-G allele tagging the
rs317657-C allele was associated with increased expression of
YEATS4 (R2 = 11.2%; p= 3.21610221) and NOD1 (R2= 9.82%;
p= 7.83610219), but with decreased expression of CNTN6
(R2= 5.9%; p= 7.56610212), CTRC (R2= 8.1%;
p= 1.54610215), COPZ2 (R2 = 9.7%; p= 2.06610218), KRT9
(R2= 5.9%; p= 1.11610211), LRRFIP1 (R2= 16.7%;
p= 6.65610232), PCDHA6 (R2 = 16.4%; p= 2.67610231), ST5
(R2= 17.0%; p= 2.51610230) and TRAF3IP2 (R2= 8.9%;
p= 5.23610217). Associations were homogeneously observed in
CAD patients and healthy subjects from CTS (Table S2).
Search for miSNP6 3utrSNP interactions
GHS discovery phase. Each 3utrSNP was tested for
interaction with all miSNPs with respect to the expression levels
of the probes tagging the 3utrSNP-associated gene. Interactions
were assessed using a standard linear regression analysis where
both SNPs coded as 0,1,2 were included to the model together
with the corresponding interaction term. Analyses were adjusted
for age and sex. The total number of tested interactions was
4,890,102.
Instead of applying the standard Bonferroni correction to
handle multiple testing, we followed the suggestion by Pare et al.
[29] and adopted a weighted-Bonferroni correction according to
the p-value of the Levene’s test. This consists in prioritizing
3utrSNPs according to the significance of the test for a difference
in the variance of expressions according to genotypes. This
strategy relies on the statistical property that a significant
difference in phenotypic variances according to sub-groups could
be a marker for interaction phenomena.
Using this weighted-Bonferroni correction, 51 miSNP 6
3utrSNP interactions were genome-wide significant at
p,1.0261028 (Table 4). Note, only 31 would have been declared
significant according the standard Bonferroni procedure (Table 4).
Seventeen of the detected interactions involved the RFPL1
rs13053624 that was found to interact with 17 miSNPs over 16
distinct miRNAs to modulate RFPL1 expression (probe
ILMN_1797383). One of these interacting miRNAs was hsa-
mir-3674. Interestingly, according to microSNiPer database [30],
RFPL1 is predicted to harbor a SNP, rs13053817, in a potential
target site for hsa-mir-3674 that is, according to the SNAP
database, in nearly complete association with the identified
rs13053624 (r2 = 0.90). No other strong biological and bioinfor-
matics evidence could be obtained from public databases
(miRanda [31], TargetScan [5], DianaMicro [32], PicTar [33],
mirBase [4]) in favour of the 30 other genes we identified through
our interaction search (Table 4).
Replication in CTS. The fifty-one genome-wide significant
interactions were tested for replication in CTS. However, only
eight interactions could be replicable, which did not include the
aforementioned interaction involving RFPL1 rs13053624.
Using the same linear regression model, further adjusted for
disease status as for the discovery phase, two interactions
replicated in CTS at the Bonferroni-corrected level of
6.2561023 (Table 5).
The first replicated interaction involved the HLA-DPB1
rs1042448 and hsa-mir-219-1 rs107822 tagged by the
rs3128923/rs213208 and rs3117222/rs439205 pairs in GHS
and CTS, respectively. These two loci are distant from about
100 kb and the corresponding tag SNPs were in modest linkage
disequilibrium (LD), r2 = 0.58 and r2 = 0.56, in GHS and CTS,
respectively. In GHS, the haplotype analysis of the rs107822 and
rs1042448 proxies revealed that the HLA-DPB1 rs1042448-A
proxy allele (i.e the allele at the proxy SNP that can be used to tag
the rs1042448-A allele) was associated with a strong increase in
HLA-DBP1 expression (b=+0.61, p= 1.646102105) when carried
on the same haplotype as the hsa-mir-219-1 rs107822-C proxy
allele (Figure 1). Conversely, when associated with the hsa-mir-
219-1 rs107822-T proxy allele, the increasing effect of the HLA-
DPB1 rs1042448-A proxy allele was significantly reduced
Table 1 Distribution of the number of 3utrSNPs (or proxy) in the 6,147 studied genes.
# 3utrSNPs
per gene
1 2 3 4 5 6 7 8 9 10 11 12 13 14 18
# genes 3,435 1,438 670 313 138 80 35 17 7 4 5 1 1 2 1
Note that, in some instances, a genotyped SNP can serve as a proxy (r2 .0.90) for several 3utr SNPs. This explains why the total number of 3utr proxy SNPs that can be
derived from this table (11,353 = 163,435 + 261,438 + 3*670 + .....) is slightly higher than the number of really studied SNPs (10,783).
doi:10.1371/journal.pone.0045863.t001
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(p = 1.88610220) and became b=+0.18 (p = 3.4961028) illustrat-
ing the interaction phenomenon identified through linear regres-
sion analysis. This interaction remained significant
(p = 2.81610212) when the haplotype analysis was further adjusted
on the best cis eSNP observed for HLA-DBP1 expression,
rs3128963 (p = 2.306102151) (see GHS_Express database [23]).
The same pattern of associations was observed in CTS (Figure 1).
The HLA-DPB1 rs1042448-A proxy allele was associated with a
strong significant increase in HLA-DPB1 expression (b= +0.63,
p = 5.24610262) when carried on the same haplotype as the hsa-
mir-219-1 rs107822-C proxy allele. The corresponding increase
when the rs1042248-A proxy allele was associated with the hsa-
mir-219-1 rs107822-A proxy allele was significantly reduced
(p = 2.68610220) and did no longer reach significance
(b= +0.05; p = 0.23) (Figure 1).
The second replicated interaction involved the H1F0
rs1894644 and hsa-mir-659 rs5750504 tagged by the rs763137/
rs2899293 and rs1894644/rs6000905 pairs in GHS and CTS,
respectively (Figure 2). These two loci are distant from about
40 kb and the corresponding tag SNPs were in low LD, r2 = 0.15
and r2 = 0.14, in GHS and CTS, respectively. In GHS and in
CTS, the H1F0 rs1894644-T proxy allele was associated with a
strong increase in H1F0 expression (b= +0.65, p = 1.71610253
and b= +0.79, p = 1.36610240, respectively) when it was on the
same haplotype as the rs5750504-T proxy allele. Conversely,
when the rs1894644-T proxy allele was on the same haplotype as
the rs5750504-A proxy allele, the corresponding increase in
H1F0 expression was lower (b= +0.23, p = 9.74610213 and
b= +0.26, p = 7.2561028, respectively). The test for homogeneity
of the H1F0 rs1894644 effect according to the rs5750504 proxy
was significant p = 3.03610212 and p= 5.67610210 in GHS and
CTS, respectively, validating the interaction detected through
standard linear regression analysis (p = 2.98610210 and
p= 1.3761028, respectively). Note that, in GHS, the rs763137
SNP involved in this interaction was the best cis eSNP for H1F0
(p = 1.10610262).
As shown in Table S3, the two replicated interactions were
consistent in CAD and healthy subjects composing CTS.
Table 2 Cis and trans-associations observed with the hsa-mir-1279 rs1463335(1).
Associated Gene Expression GHS CTS
Probe Gene CHR Start End b(2) SE P(3) b(2) SE P(3)
ILMN_1748730 CTRC 1 15764937 15773152 20.03 0.004 1.39 10213 20.06 0.007 1.54 10215
ILMN_2252021 LRRFIP1 2 238536223 238690289 20.05 0.004 1.50 10235 20.12 0.010 6.65 10232
ILMN_1699317 CNTN6 3 1134628 1445277 20.02 0.003 1.16 10212 20.04 0.006 7.56 10212
ILMN_1740494 PCDHA6 5 140207649 140391928 20.04 0.003 9.44 10233 20.10 0.008 2.67 10231
ILMN_1663381 TRAF3IP2 6 111880142 111927320 20.03 0.003 2.74 10217 20.06 0.007 5.23 10217
ILMN_2114422 NOD1 7 30464142 30518392 0.05 0.008 7.25 1029 0.12 0.013 7.83 10219
ILMN_1731063 ST5 11 8714898 8932497 20.06 0.007 2.05 10218 20.22 0.019 2.51 10230
ILMN_1815205 LYZ(1) 12 69742133 69748012 0.20 0.010 1.36 10276 NA NA NA
ILMN_1801387 YEATS4(1) 12 69753531 69784575 0.15 0.010 1.32 10246 0.19 0.020 3.27 10221
ILMN_1792568 KRT9 17 39722092 39728309 20.04 0.006 1.15 10215 20.11 0.016 1.11 10211
ILMN_1667361 COPZ2 17 46103532 46115151 20.03 0.005 2.33 10211 20.10 0.011 2.06 10218
(1)The rs1463335 was tagged by the rs317657 and rs998022 in GHS and CTS, respectively. The rs146335 is located on chromosome 12, at position 69,667,075. As a
consequence, the association observed with LYZ and YEATS4 are considered as cis-associations, the remaining eight as trans-associations.
(2)Regression coefficient associated with the rare miSNP allele under an additive effect model, adjusted for age and gender
(3)P-value of the association between miSNP and gene expression
doi:10.1371/journal.pone.0045863.t002
Table 3 Correlation between gene expressions influenced by the rs317657 tagging the hsa-mir-1279 rs1463335.
CTRC LRRFIP1 CNTN6 PCDHA6 TRAF3IP2 NOD1 ST5 LYZ YEATS4 KRT9
LRRFIP1 0.204 1
CNTN6 0.137 0.237 1
PCDHA6 0.202 0.449 0.200 1
TRAF3IP2 0.129 0.271 0.202 0.270 1
NOD1 0.225 20.126 0.047 20.062 0.029 1
ST5 0.210 0.517 0.192 0.411 0.274 20.176 1
LYZ 20.156 20.143 20.070 20.125 20.170 0.113 20.125 1
YEATS4 20.079 20.162 20.110 20.113 20.250 20.070 20.140 0.558 1
KRT9 0.217 0.485 0.168 0.402 0.302 20.166 0.740 20.133 20.121 1
COPZ2 0.188 0.400 0.131 0.341 0.236 20.140 0.592 20.143 20.093 0.590
doi:10.1371/journal.pone.0045863.t003
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Table 4 Genome-wide significant (p,1.02 1028) interactions between miSNPs and 3utrSNPs on monocyte gene expression in the
Gutenberg Health Study.
GHS
Gene CHR Probe 3utrSNP miRNA CHR miSNP miProxy 3utrProxy P(1)
Levene
P-value weighted P(2)
RFPL1 22 ILMN_1797383 rs13053624 hsa-mir-592 7 rs11563750 rs11563505 rs13053817 1.04 10235 3.22 1025 1.50 10236
RFPL1 22 ILMN_1797383 rs13053624 hsa-mir-3920 11 rs12275715 rs12283329 rs13053817 1.21 10226 3.22 1025 1.74 10227
TXNDC5 6 ILMN_1769082 rs8643 hsa-mir-125b-2 21 rs2823897 rs2211981 rs8643 8.95 10218 3.39 1021 1.23 10217
TXNDC5 6 ILMN_1769082 rs1043784 hsa-mir-125b-2 21 rs2823897 rs2211981 rs3734589 1.26 10217 3.18 1021 1.64 10217
LYZ 12 ILMN_1815205 rs710794 hsa-mir-1279 12 rs1463335 rs317657 rs710794 4.13 10215 4.51 10223 1.20 10216
ASB1 2 ILMN_1683096 rs1044561 hsa-mir-125b-2 21 rs2823897 rs2211981 rs2334004 1.45 10216 8.91 1021 1.87 10215
RFPL1 22 ILMN_1797383 rs13053624 hsa-mir-4656 7 rs3750013 rs17135110 rs13053817 2.28 10214 3.22 1025 3.29 10215
ASB1 2 ILMN_1683096 rs2278768 hsa-mir-3119-1 1 rs17349873 rs1330387 rs2278768 3.71 10214 1.34 1026 4.10 10215
RFPL1 22 ILMN_1797383 rs13053624 hsa-mir-30c-1 1 rs16827546 rs16827546 rs13053817 2.89 10214 3.22 1025 4.16 10215
ECE1 1 ILMN_1672174 rs3026907 hsa-mir-1307 10 rs7911488 rs2271751 rs9287035 2.98 10213 9.07 10246 4.29 10215
RFPL1 22 ILMN_1797383 rs13053624 hsa-mir-125b-1 11 rs2081443 rs2081443 rs13053817 2.40 10213 3.22 1025 3.47 10214
PKD1L2 16 ILMN_1742788 rs1901818 hsa-mir-4272 3 rs9868022 rs9868022 rs7198127 8.92 10214 8.80 1022 5.47 10214
ECE1 1 ILMN_1672174 rs3026907 hsa-mir-4670 9 rs2104533 rs2296666 rs9287035 5.16 10212 9.07 10246 7.42 10214
ASB1 2 ILMN_1683096 rs2278768 hsa-mir-125b-2 21 rs2823897 rs2211981 rs2278768 5.30 10212 1.34 1026 5.85 10212
RFPL1 22 ILMN_1797383 rs13053624 hsa-mir-4300 11 rs11603185 rs7944477 rs13053817 2.02 10211 3.22 1025 2.92 10212
SPRY1 4 ILMN_2329914 rs300574 hsa-mir-4666 1 rs16841344 rs4653963 rs300555 1.52 10211 1.16 1022 5.10 10212
HLA-DPB1 6 ILMN_1749070 rs1042448 hsa-mir-219-1 6 rs107822 rs213208 rs3128923 1.26 10210 4.11 1028 1.11 10211
ASB1 2 ILMN_1683096 rs2278768 hsa-mir-4636 5 rs257095 rs6555591 rs2278768 1.09 10210 1.34 1026 1.20 10211
RFPL1 22 ILMN_1797383 rs13053624 hsa-mir-4292 9 rs2811749 rs2811749 rs13053817 1.98 10210 3.22 1025 2.86 10211
RFPL1 22 ILMN_1797383 rs13053624 hsa-mir-624 14 rs11156654 rs11156654 rs13053817 2.20 10210 3.22 1025 3.18 10211
GPRC5C 17 ILMN_1724211 rs2706527 hsa-mir-3667 22 rs135771 rs135775 rs2706526 5.46 1029 5.08 10279 4.52 10211
H1F0 22 ILMN_1757467 rs1894644 hsa-mir-659 22 rs5750504 rs2899293 rs763137 2.98 10210 1.30 1021 2.18 10210
ECE1 1 ILMN_1672174 rs3026907 hsa-mir-548n 7 rs1649215 rs1637670 rs9287035 1.64 1028 9.07 10246 2.37 10210
RFPL1 22 ILMN_1797383 rs13053624 hsa-mir-521-1 19 rs4803178 rs4803178 rs13053817 2.88 1029 3.22 1025 4.16 10210
GPRC5C 17 ILMN_2352090 rs2706527 hsa-mir-3667 22 rs135771 rs135775 rs2706526 1.06 1027 6.63 102102 6.80 10210
GPRC5C 17 ILMN_2352090 rs2706527 hsa-mir-107 10 rs17481096 rs17481096 rs2706526 1.20 1027 6.63 102102 7.69 10210
HLA-DPB1 6 ILMN_1749070 rs1042448 hsa-mir-219-1 6 rs213210 rs213210 rs3128923 8.98 1029 4.11 1028 7.88 10210
MXRA7 17 ILMN_1743836 rs10473 hsa-mir-490 7 rs6963819 rs2350780 rs7221855 2.66 1027 6.10 102167 1.04 1029
SPRY1 4 ILMN_1651610 rs300574 hsa-mir-4666 1 rs16841344 rs4653963 rs300555 3.82 1029 6.28 1023 1.12 1029
RFPL1 22 ILMN_1797383 rs13053624 hsa-mir-1236 6 rs403569 rs550513 rs13053817 7.89 1029 3.22 1025 1.14 1029
GPRC5C 17 ILMN_2352090 rs2706527 hsa-mir-941-1 20 rs2427555 rs2427554 rs2706526 2.03 1027 6.63 102102 1.30 1029
POGZ 1 ILMN_2329309 rs3811409 hsa-mir-4666 1 rs16841344 rs4653963 rs3811409 2.24 1029 1.12 1021 1.53 1029
RFPL1 22 ILMN_1797383 rs13053624 hsa-mir-4643 6 rs16884450 rs16884450 rs13053817 1.28 1028 3.22 1025 1.85 1029
ASB1 2 ILMN_1683096 rs1044561 hsa-mir-3973 11 rs262404 rs16928224 rs2334004 1.60 10210 8.91 1021 2.06 1029
RFPL1 22 ILMN_1797383 rs13053624 hsa-mir-3646 20 rs11574730 rs11574730 rs13053817 1.70 1028 3.22 1025 2.45 1029
ECE1 1 ILMN_1672174 rs3026907 hsa-mir-4460 5 rs13171514 rs13171514 rs9287035 2.47 1027 9.07 10246 3.55 1029
RFPL1 22 ILMN_1797383 rs13053624 hsa-mir-3674 8 rs7003112 rs6558541 rs13053817 2.55 1028 3.22 1025 3.67 1029
RFPL1 22 ILMN_1797383 rs13053624 hsa-mir-1205 8 rs9649959 rs9649959 rs13053817 2.78 1028 3.22 1025 4.02 1029
RFPL1 22 ILMN_1797383 rs13053624 hsa-mir-4656 7 rs17829969 rs17829969 rs13053817 2.82 1028 3.22 1025 4.07 1029
ECE1 1 ILMN_1672174 rs3026907 hsa-mir-4784 2 rs6709245 rs12463867 rs9287035 3.22 1027 9.07 10246 4.63 1029
AAK1 2 ILMN_1880387 rs13427243 hsa-mir-3667 22 rs135771 rs135775 rs13427243 7.28 1029 1.04 1021 4.80 1029
RFPL1 22 ILMN_1797383 rs13053624 hsa-mir-604 10 rs2368392 rs3758371 rs13053817 3.69 1028 3.22 1025 5.32 1029
ECE1 1 ILMN_1672174 rs3026907 hsa-mir-215 1 rs3820455 rs34406824 rs9287035 3.88 1027 9.07 10246 5.58 1029
RBM12 20 ILMN_1670841 rs6060539 hsa-mir-4755 20 rs2284385 rs2284390 rs2425125 4.06 1027 1.65 10247 5.62 1029
ECE1 1 ILMN_1672174 rs3026907 hsa-mir-2113 6 rs9375085 rs9375085 rs9287035 4.02 1027 9.07 10246 5.79 1029
RFPL1 22 ILMN_1797383 rs13053624 hsa-mir-1269b 17 rs7210937 rs2240567 rs13053817 4.93 1028 3.22 1025 7.10 1029
ECE1 1 ILMN_1672174 rs3026907 hsa-mir-4705 13 rs7337292 rs7337292 rs9287035 5.10 1027 9.07 10246 7.33 1029
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Discussion
Coupling genome-wide association and expression studies have
been an attractive strategy to disentangle the architecture of the
genetics of gene expression and to assess whether gene expression
dysregulation could mediate the effect of SNPs on disease risk
identified through genome-wide association studies [23,34]. To
our knowledge, such studies [23,34–37] mainly focused on
assessing marginal associations of single SNPs with gene expres-
sion. Even if SNP6SNP interactions have often been advocated
as a potential source of phenotype variability [38,39], there has
been few attempt to assess at the genome-wide scale whether such
SNP 6 SNP interactions could influence gene expression
variability. This is likely due to the statistical and computing
burdens associated with such investigations characterized by a
huge number of tested interactions and the very large sample size
required to detect genome-wide significance. We postulated that
focusing on plausible ‘‘biological’’ interactions could be one
strategy to dig into the complex architecture of SNP 6 SNP
interactions. This is why we undertook what we think is the first
systematic and comprehensive search for interactions between
SNPs located in the genomic sequence of miRNAs and SNPs
located in the 3’UTR gene regions that could participate in
monocyte gene expression. This search for interactions was
preceded by a genome-wide investigation of miSNPs effect on
monocyte expression to assess whether miSNPs could influence
gene expression, in particular, through trans regulation.
These investigations were conducted in the Gutenberg Health
Study where the extensive genome-wide study of marginal SNP
associations with monocyte expressions had previously been
reported and the results stored in a publicly available resource
[23], and we replicated the significant findings in the Cardiogenics
study.
Our survey of marginal miSNP effect has pointed out the hsa-
mir-1279 miRNA mapping to chromosome 12q15 as a candidate
regulator of 10 genes in monocytes. Indeed, we observed that the
hsa-mir-1279 rs1463335 tagged by rs317657 or rs1463335 was
Table 5 Replication in Cardiogenics of the miSNPs6 3utrSNPs detected in Gutenberg Health Study.
MiSNP
6
3utrSNP
rs17349873
rs2278768
rs107822
rs1042448
rs257095
rs2278768
rs5750504
rs1894644
rs6963819
rs10473
rs262404
rs1044561
rs2284385
rs6060539
rs257095
rs1044561
miRNA
(CHR)
hsa-mir-3119-1
(1)
hsa-mir-219-1
(6)
hsa-mir-4636
(5)
hsa-mir-659
(22)
hsa-mir-490
(7)
hsa-mir-3973
(11)
hsa-mir-4755
(20)
hsa-mir-4636
(5)
Gene
(CHR)
ASB1
(2)
HLA-DPB1
(6)
ASB1
(2)
H1F0
(22)
MXRA7
(7)
ASB1
(2)
RBM12
(20)
ASB1
(2)
Probe ILMN_1683096 ILMN_1749070 ILMN_1683096 ILMN_1757467 ILMN_1743836 ILMN_1683096 ILMN_1670841 ILMN_1683096
Gutenberg Health Study
Proxies rs1330387
rs2278768
rs213208
rs3128923
rs6555591
rs2278768
rs2899293
rs763137
rs2350780
rs7221855
rs16928224
rs2334004
rs2284390
rs2425125
rs6555591
rs2334004
b (1) 20.480 20.165 20.233 20.194 20.065 0.988 0.164 0.375
Weighted
P-value (2)
4.10 10215 1.11 10211 1.20 10211 2.18 10210 1.04 1029 2.06 1029 5.62 1029 9.74 1029
Cardiogenics Transcriptomic Study
Proxies rs6703198
rs10084192
rs439205
rs3117222
rs257095
rs10084192
rs6000905
rs1894644
rs2350780
rs9910052
rs262407
rs10084192
rs2038123
rs6121015
rs257095
rs10084192
b (1) 0.093 20.274 0.045 20.268 0.011 20.025 0.099 0.045
P-value (3) 4.62 1021 2.03 10213 5.18 1021 1.37 1028 5.98 1021 8.29 1021 7.22 1022 5.18 1021
(1) Regression coefficient of the interaction term when both miSNP and 3utr proxy SNPs coded 0/1/2 according to the number of carried rare alleles are introduced in a
linear regression model together with their interaction term.
(2) P-value of the interaction test obtained in GHS when the Levene test p-value was used under a weighted-Bonferroni framework.
(3) P-value of the interaction test derived from the standard linear regression analysis in Cardiogenics. Bold p-values are significant after Bonferroni correction.
doi:10.1371/journal.pone.0045863.t005
Table 4. Cont.
GHS
Gene CHR Probe 3utrSNP miRNA CHR miSNP miProxy 3utrProxy P(1)
Levene
P-value weighted P(2)
PKD1L2 16 ILMN_1742788 rs1901818 hsa-mir-4473 9 rs16938058 rs16938057 rs7198127 1.24 1028 8.80 1022 7.60 1029
MRPL43 10 ILMN_1678974 rs2295716 hsa-mir-608 10 rs4919510 rs4919510 rs3824783 3.06 1027 9.68 10222 9.44 1029
ECE1 1 ILMN_1672174 rs3026907 hsa-mir-520d 19 rs2217653 rs9304754 rs9287035 6.62 1027 9.07 10246 9.52 1029
ASB1 2 ILMN_1683096 rs1044561 hsa-mir-4636 5 rs257095 rs6555591 rs2334004 7.57 10210 8.91 1021 9.74 1029
(1) P-value of the interaction test derived from the standard linear regression analysis
(2) P-value of the interaction test obtained when the Levene test p-value was used under a weighted-Bonferroni framework.
doi:10.1371/journal.pone.0045863.t004
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robustly associated in cis with LYZ expression and in trans with
CNTN6, CTRC, COPZ2, KRT9, LRRFIP1, NOD1, PCDHA6, ST5
and TRAF3IP2. The bioinformatics prediction of the LYZ gene as
a target for hsa-mir-1279 miRNA supports this hypothesis. The
lack of strong correlation between the expression of these 10 genes,
together with the trans association observed after adjusting for LYZ
expression, could suggest that these nine genes could also be
targets for the hsa-mir-1279, despite the absence of such prediction
by current bioinformatics tools. However, the observation of
positive associations with LYZ and NOD1, but of negative
associations with the other genes, is puzzling as we could have
expected, at first sight, a similar pattern of associations if all these
genes were target for hsa-mir-1279. Functional experimental work
is needed to characterize the role of hsa-mir-1279 in the regulation
of these genes in-depth, in particular TRAF3IP2 as this gene was
identified in two independent GWAS as a susceptibility locus for
psoriasis [40,41]. Our results, if confirmed, could open therapeu-
tics perspectives as it is possible to use artificial miRNA targets to
modify gene expression [42,43]. A trans association pattern was
also recently observed at the locus 12q15 using an unsupervised
gene networks analysis of the same datasets [24]. The rs11177644
located in the 3’UTR region of the YEATS4 gene was also found
associated in cis to LYZ and YEATS4 and in trans with a module of
36 genes including the CNTN6, CTRC, COPZ2, KRT9, LRRFIP1,
NOD1 and ST5 discussed above. However, unlike what we
observed here with hsa-mir-1279 rs1463335, the trans associations
with rs11177644 had been found mediated by cis regulation
mechanisms. Using a standard linear regression analysis (see
above), we then tested whether these two SNPs could interact to
contribute to the identified trans associations. We did not observe
any strong evidence for such phenomenon as the lowest p-value
for interaction was p= 8.5361024 for PCDHA6 (data not shown).
As the rs11177644 and rs1463335 were in moderate LD (r2 = 0.30
and D’= +0.70), we further conducted an haplotype analysis of the
two SNPs (Table 6). This revealed that both SNPs acted additively
on LYZ expression but, after adjusting for rs11177644, the
association of rs1463335 with YEATS4 was no longer significant
(p = 0.748). This haplotype analysis also revealed strong trans
haplotype associations, which were due to a single haplotype,
(rs317657_C/rs11177644_A), which was, after adjusting for LYZ
Figure 2. H1F0 rs1894644 6 hsa-mir-659 rs5750504 interaction on H1F0 monocyte expression. In the Gutenberg Health Study, the
rs1894644/rs5750504 pair was tagged by rs763137/rs2899293. In the Cardiogenics Transcriptomic Study, the corresponding tagging pair was
rs1894644/rs6000905.
doi:10.1371/journal.pone.0045863.g002
Figure 1. HLA-DPB1 rs10424486hsa-mir-219-1 rs107822 interaction on HLA-DPB1monocyte expression. In the Gutenberg Health Study,
the rs1042248/rs107822 pair was tagged by rs3128923/rs213208. In the Cardiogenics Transcriptomic Study, the corresponding tagging pair was
rs3117222/rs439205.
doi:10.1371/journal.pone.0045863.g001
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and YEATS4 expression, strongly associated with increased levels
of NOD1 (p = 8.30610213), and decreased levels of the eight other
genes, with p-values ranging from 2.2161026 to 2.52610238
(Table 6). These results suggest that the associations observed at
the 12q15 locus are much more complex as initially hypothesized.
It appeared that YEATS4 and LYZ expressions could be under the
influence of a common cis eSNP, but the latter would also be
additionally influenced by a miSNP contributing to trans associ-
ations. As discussed in the following paragraph, further investi-
gating including molecular experiments are required to dissect this
complex pattern of association.
Two interactions miSNPs63utrSNPs were robustly identified,
the first involving HLA-DPB1 rs1042448 and hsa-mir-219-1
rs107822, the second the H1F0 rs1894644 and hsa-mir-659
rs5750504. In both cases, the identified 3’UTR rare alleles were
found to strongly increase the expression of the associated genes,
but these over-expressions were highly reduced in carriers of
miSNPs rare alleles. The identified miSNPs are not located within
the mature sequence of the associated miRNAs but in their pri-
miRNA sequences. These rare alleles could either be associated
with increased miRNA expression or could tag for yet-unknown
miSNPs within mature sequences leading to the production of
isomiRs. It could be speculated that the associated miRNAs or
isomiRs would then target the identified 3’UTR regions made
sensitive to miRNAs regulation by the identified 3’UTR variants,
variants that could create novel motifs for miRNAs’ binding and
would lead to reduction of the per se effect of the 3’UTR variant.
Molecular constructs are required to assess such hypothesis. We
further checked whether the identified miSNPs could interact with
other 3’UTR SNPs located in genes in the vicinity of the HLA-
DBP1 and H1F0 loci. We did not observe any suggestive evidence
(P,0.05) for such interaction suggesting that the identified
miRNA regulation would be specific to HLA-DBP1 and H1F0.
The identified interactions involved SNPs in modest LD but
located within a genomic distance of less than 100 kb. Several
examples have already been observed where a given miRNA
participates to the regulation of a gene located in its very close
vicinity [2,3,44,45]. Nevertheless, one cannot exclude the possi-
bility that the detected interactions are tagging for other complex
haplotypic effects spanning a large distance and over several genes,
five genes lying between HLA-DPB1 and hsa-mir-219-1 and three
between H1F0 and hsa-mir-659 (Figure 3). Additional functional
experiments would be required to biologically characterize the
detected statistical interactions.
Little is known about H1F0 in human diseases except that it
codes for a histone family member protein. Interestingly, hsa-mir-
659 has been shown to influence the risk of dementia [46] through
a mechanism that could involve histone deacetylation [47,48].
Although speculative, the joint contribution of H1F0 and hsa-mir-
659 on the risk of dementia could deserve further attention.
Conversely the HLA-DPB1 gene has been associated with several
complex diseases such as pulmonary hypertension, hepatitis B
infection and systemic sclerosis [49–51]. In addition, hsa-mir-219-
1 was suggested to play a role in schizophrenia and in N-methyl-
D-aspartate (NMDA) glutamate receptor signaling, two patho-
physiological mechanisms linked to HLA-DPB1 [52,53] making
our results of valuable information for scientists interested in these
pathologies.
Several limitations of this work must be acknowledged. First,
because our investigation was conducted on genotyped data of
common SNPs, only 258 miRNAs were covered by our study,
which represent less than one-quarter of the hypothesized total
number of human miRNAs. Second, only one cell type was
studied where not all genes are expressed. Therefore not all
possible association could be explored. Third, expression were
measured using the microarray technology that may be less
efficient than emerging mRNA deep-sequencing methods for
measuring, especially low abundant, mRNA levels [54,55].
Because a given miRNA can bind several genes and a given
3’UTR can be a target for several miRNAs, compensation
Figure 3. Location of genes, miSNP and 3’UTR SNPs at the two detected interacting loci. Gene are indicated as black rectangles with grey
3’UTR. Bold red and blue SNPs represent miSNPs and 3utrSNPs respectively. Corresponding proxies are non-bold coloured. Top: HLA-DBP1 locus on
chromosome 6; Bottom: H1F0 locus on chromosome 22.
doi:10.1371/journal.pone.0045863.g003
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phenomena are proposed to explain the relative low impact of
miRNA regulation on mRNA expression generally observed [56].
Therefore, genetic effects associated with miRNA and 3’UTR
SNPs are hypothesized to be a modest size and very large sample
size would be required to detect them. Despite having robustly
identified two interactions, we cannot then exclude that other
interactions with lower magnitude could have been missed due to
power considerations, even if the two genome-wide expression
datasets used in this work are among the largest collected so far in
human epidemiological studies. Third, by discarding from our
investigations probes harboring a SNP in their genomic sequence
to avoid any bias in the results of the association analyses, some
miRNA-sensitive regulatory mechanisms associated to genes
tagged by probes matching their 3’UTR region may have been
missed. Last, our investigation was conducted in monocytes and
results observed may not be portable to other cells or tissues.
Nevertheless, our study illustrates that the proposed strategy
searching for interaction between miSNPs and 3’UTR SNPs in
genome-wide expression studies could be an alternative to
bioinformatics prediction tools to identify miRNA targeted genes.
Materials and Methods
Ethics Statement
This work was based on two genome-wide expression studies,
the Gutenberg Health Study (GHS) for the discovery phase and
the Cardiogenics Transcriptomic Study (CTS) for the replication
stage. Both studies were approved by the Institutional Ethical
Committee of each participating center and by the local and
federal data safety commissioners (Ethik-Kommission der Land-
esa¨rztekammer Rheinland-Pfalz) for GHS. These two studies have
already been extensively described in [21–23] for GHS and in
[26,57] for CTS.
Gutenberg Health Study
This analysis was conducted in a population-based sample of
750 men and 717 women aged 35–74 years, of European descent.
Monocytic RNA was isolated from peripheral blood monocytes by
negative selection using RosetteSep Monocyte Enrichment Cock-
tail (StemCell Technologies, Vancouver, Canada), Trizol extrac-
tion and purification by silica-based columns. Expression profiles
were assessed using the Illumina HT-12 v3 BeadChip (Illumina,
CA, USA) with ,48,000 probes covering 37,804 genes, and
generated data were pre-processed using Beadstudio. Values from
probes with#1 bead were re-imputed using SVD impute from the
pcaMethods R package [58]. Data were normalized using quantile
normalization and VST transformation as implemented in the
lumi R package. To avoid spurious associations due to hybridation
difference, probes that contained SNPs or were not annotated to
be of ‘‘perfect’’ quality according to ReMOAT [28] (Reannotation
and Mapping of Oligonucleotide Arrays Technologies, http://
remoat.sysbiol.cam.ac.uk) were discarded. Individuals were typed
for genome-wide genotype data using the Affymetrix Genome-
Wide Human SNP Array 6.0 (Affymetrix, CA, USA). SNP
analysis was restricted to autosomal SNPs with minor allele
frequency .0.01, call rate .0.98 and Hardy-Weinberg equilib-
rium testing p-value .1024.
Cardiogenics Study
The present study included monocyte expression data from 758
individuals from European descent, 363 patients with coronary
artery disease and 395 unrelated healthy individuals.
Monocyte RNAs were isolated from whole blood using CD14
micro beads (Miltenyi) and expression profile was processed in a
single center using the Illumina HumanRef-8 v3 beadchip array
(Illumina Inc., San Diego, CA) containing 24,516 probes corre-
sponding to 18,311 distinct genes. After hybridization, array
images were scanned using the Illumina BeadArray Reader and
probe intensities were extracted using the Gene expression module
(version 3.3.8) of the Illumina BeadStudio software (version 3.1.30).
Raw intensities were processed in R statistical environment using
the Lumi and beadarray packages. All array outliers were
excluded and only arrays with high concordance in terms of gene
expression measures (pairwise Spearman correlation coefficients
within each cell type .0.85) were included in the analyses.
Genomic DNA was extracted from peripheral blood leucocytes
by standard procedures (Qiagen). Genome-wide genotyping was
carried out using one of two Illumina arrays; the Sentrix Human
Custom 1.2 M array and the Human 610 Quad Custom array.
Data from the two arrays was combined as described in [59]. SNP
analysis was restricted to autosomal SNPs with minor allele
frequency .0.01, call rate .0.95 and Hardy-Weinberg equilib-
rium testing p-value .1025.
Statistical analysis
The association of miSNP proxies with probe expression was
tested by use of a standard linear regression model under the
assumption of additive allele effects (i.e. proxy genotype coded as
0/1/2 according the number of rare alleles). Pair-wise SNPs
interactions on probe expression were tested using a standard
linear regression model in which both SNP (miSNP and 3utrSNP)
genotypes were coded as 0,1,2 together with the corresponding
product term for interaction. All analyses were adjusted for age
and gender, and additionally for disease status in CTS.
In the Gutenberg Health Study, a weighted-Bonferroni
procedure was applied to identify genome-wide significant
interactions. Each 3utrSNP was first assessed using the Levene
statistic [29] testing the equality of associated-probe expression
variance across genotypes. The resulting log(p-value) was then
used to weight the interaction p-value obtained from the linear
regression analysis. This strategy is expected to be more powerful
than a standard Bonferroni correction procedure [60,61] as it
gives more weight to interaction involving probes showing higher
differences in inter-genotype variance.
For each 3utrSNP u (u=1 to Nutr) associated with a Levene test
p-value qu, we define a standardized weight wu as
wu~ NutrxNmiSNPð Þlog quð Þ
PNutr
i~1
NmiSNPlog quð Þ such asPN
i~1
wi~N where Nutr, NmiSNP, N are the total number of studied
3utrSNPs, miSNPs and interactions, respectively. Each interaction
p-value Pi is then weighted by the wu corresponding to the
3utrSNP that is involved in the interaction, leading to a weighted
p-value Pi*. Each Pi* that is then below 0.05/N is then declared
genome-wide significant at the 0.05 type I error.
In Cardiogenics, the standard Bonferroni threshold was used to
declare significance.
Identified interactions between pairs of SNPs were illustrated
through haplotype analyses conducted by the THESIAS software
implementing a Stochastic-EM algorithm for haplotype-based
association analysis [62]. All other statistical analyses were
performed in R v. 2.12.0.
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